Robert Weinstein

Chief Accounting Officer, Principal Financial Officer and Principal Accounting Officer, Petros Pharmaceuticals, Inc.

Former. First published here October 28, 2026; built from records as of October 28, 2026.

Petros Pharmaceuticals, Inc. reported the departure of Robert Weinstein from the chief financial officer seat, effective September 30, 2026.² Petros Pharmaceuticals, Inc. appointed Robert Weinstein as Chief Accounting Officer, Principal Financial Officer and Principal Accounting Officer, effective June 18, 2026.¹

The filing gives Robert Weinstein's previous role as Chief Financial Officer at TAO Synergies Inc.¹ Robert Weinstein joined from outside Petros Pharmaceuticals, Inc., by the record's reading of the filing.¹ The filing shows an earlier chief financial officer seat, so this is not Robert Weinstein's first.¹

Seats

The seat in the record

Company	Title as filed	Standing	Filings
Petros Pharmaceuticals, Inc. (PTPI) Pharmaceutical Preparations	Chief Accounting Officer, Principal Financial Officer and Principal Accounting Officer	Former	2

Company names link to the company's page in the record at CFO Tribune, which holds the seat history.

The record

Filing by filing, latest first

September 30, 2026effective
Petros Pharmaceuticals, Inc. reported the departure of Robert Weinstein from the chief financial officer seat, effective September 30, 2026.
Eastern time, Robert Weinstein resigned as Chief Accounting Officer, Principal Financial Officer, and Principal Accounting Officer of the Company.
[2] Filing by Petros Pharmaceuticals, Inc., filed with the SEC on September 30, 2026. Read the filing. The record at CFO Tribune.
June 18, 2026effective
Petros Pharmaceuticals, Inc. appointed Robert Weinstein as Chief Accounting Officer, Principal Financial Officer and Principal Accounting Officer, effective June 18, 2026. Profile of Mitchell Arnold.
On June 18, 2026, the board of directors (the “Board”) of the Company appointed Robert Weinstein to the positions of Chief Accounting Officer, Principal Financial Officer and Principal Accounting Officer of the Company, effective immediately.
[1] Filing by Petros Pharmaceuticals, Inc., filed with the SEC on June 18, 2026. Read the filing. The record at CFO Tribune.

Sources

Current report filed with the SEC, Petros Pharmaceuticals, Inc.. U.S. Securities and Exchange Commission, EDGAR, filed June 18, 2026. sec.gov; record.
Current report filed with the SEC, Petros Pharmaceuticals, Inc.. U.S. Securities and Exchange Commission, EDGAR, filed September 30, 2026. sec.gov; record.

Corrections and removal

If a line here is wrong, or Robert Weinstein wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.